{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T15:33:07Z","timestamp":1795015987787,"version":"4.10.1"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["J Trauma Acute Care Surg"],"published-print":{"date-parts":[[2024,10]]},"abstract":"<jats:sec>\n                    <jats:title>BACKGROUND<\/jats:title>\n                    <jats:p>In the prehospital tranexamic acid (TXA) for traumatic brain injury (TBI) trial, TXA administered within 2 hours of injury in the out-of-hospital setting did not reduce mortality in all patients with moderate\/severe traumatic brain injury (TBI). We examined the association between TXA dosing arms, neurologic outcome, and mortality in patients with intracranial hemorrhage (ICH) on computed tomography (CT).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS<\/jats:title>\n                    <jats:p>This was a secondary analysis of the Prehospital Tranexamic Acid for TBI Trial (ClinicalTrials.gov [NCT01990768]) that randomized adults with moderate\/severe TBI (Glasgow Coma Scale score &lt; 13) and systolic blood pressure \u2265 90 mm Hg within 2 hours of injury to a 2-g out-of-hospital TXA bolus followed by an in-hospital saline infusion, a 1-g out-of-hospital TXA bolus\/1-g in-hospital TXA infusion, or an out-of-hospital saline bolus\/in-hospital saline infusion (placebo). This analysis included the subgroup with ICH on initial CT. Primary outcomes included 28-day mortality, 6-month Glasgow Outcome Scale-Extended (GOSE) \u2264 4, and 6-month Disability Rating Scale (DRS). Outcomes were modeled using linear regression with robust standard errors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>The primary trial included 966 patients. Among 541 participants with ICH, 28-day mortality was lower in the 2-g TXA bolus group (17%) compared with the other two groups (1-g bolus\/1-g infusion 26%, placebo 27%). The estimated adjusted difference between the 2-g bolus and placebo groups was \u22128\u00b75 percentage points (95% confidence interval [CI], \u221215.9 to \u22121.0) and between the 2-g bolus and 1-g bolus\/1-g infusion groups was \u221210.2 percentage points (95% CI, \u221217.6 to \u22122.9). Disability Rating Scale at 6 months was lower in the 2-g TXA bolus group than the 1-g bolus\/1-g infusion (estimated difference \u2212 2.1 [95% CI, \u22124.2 to \u22120.02]) and placebo groups (\u22122.2 [95% CI, \u22124.3, \u22120.2]). Six-month GOSE did not differ among groups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION<\/jats:title>\n                    <jats:p>A 2-g out-of-hospital TXA bolus in patients with moderate\/severe TBI and ICH resulted in lower 28-day mortality and lower 6-month DRS than placebo and standard TXA dosing.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>LEVEL OF EVIDENCE<\/jats:title>\n                    <jats:p>Therapeutic\/Care Management; Level II.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/ta.0000000000004354","type":"journal-article","created":{"date-parts":[[2024,4,30]],"date-time":"2024-04-30T00:02:32Z","timestamp":1714435352000},"page":"572-580","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":21,"title":["The effects of prehospital TXA on mortality and neurologic outcomes in patients with traumatic intracranial hemorrhage: A subgroup analysis from the prehospital TXA for TBI trial"],"prefix":"10.1097","volume":"97","author":[{"given":"Susan","family":"Rowell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric N.","family":"Meier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana","family":"Hoyos Gomez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Fleming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon","family":"Jui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurie","family":"Morrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eileen","family":"Bulger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Sopko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myron","family":"Weisfeldt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jim","family":"Christenson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pat","family":"Klotz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"McMullan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeannie","family":"Callum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kellie","family":"Sheehan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Tibbs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Aufderheide","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan","family":"Cotton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajesh","family":"Gandhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahamed","family":"Idris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph J.","family":"Frascone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Ferrara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Richmond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delores","family":"Kannas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rob","family":"Schlamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryce","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Dries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Tallon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"Hendrickson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Gamber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Garrett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Simonson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Ian","family":"McKinley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Schreiber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,4,30]]},"reference":[{"issue":"4","key":"bib1-20250806","first-page":"1080","article-title":"Estimating the global incidence of traumatic brain injury","volume":"130","year":"2018","journal-title":"Neurosurgery"},{"issue":"46","key":"bib3-20250806","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.15585\/mmwr.mm6846a2","article-title":"Traumatic brain injury-related deaths by race\/ethnicity, sex, intent, and mechanism of injury - United States, 2000\u20132017","volume":"68","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"1","key":"bib4-20250806","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S1474-4422(18)30415-0","article-title":"Global, regional, and national burden of traumatic brain injury and spinal cord injury, 1990-2016: a systematic analysis for the global burden of disease study 2016","volume":"18","year":"2019","journal-title":"Lancet Neurol"},{"issue":"5","key":"bib5-20250806","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/MLR.0000000000001511","article-title":"Costs of nonfatal traumatic brain injury in the United States, 2016","volume":"59","year":"2021","journal-title":"Med Care"},{"issue":"1","key":"bib6-20250806","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1227\/NEU.0000000000001432","article-title":"Guidelines for the Management of Severe Traumatic Brain Injury, Fourth Edition","volume":"80","year":"2017","journal-title":"Neurosurgery"},{"issue":"5","key":"bib7-20250806","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1136\/jnnp.65.5.729","article-title":"Absence of evidence for the effectiveness of five interventions routinely used in the intensive care management of severe head injury: a systematic review","volume":"65","year":"1998","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"bib8-20250806","first-page":"CD000196","article-title":"Corticosteroids for acute traumatic brain injury","volume":"2005","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"bib9-20250806","first-page":"CD005400","article-title":"Magnesium for acute traumatic brain injury","volume":"4","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"bib10-20250806","first-page":"CD001527","article-title":"Aminosteroids for acute traumatic brain injury","volume":"1999","year":"2000","journal-title":"Cochrane Database Syst Rev"},{"key":"bib11-20250806","first-page":"CD000565","article-title":"Calcium channel blockers for acute traumatic brain injury","volume":"4","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"bib12-20250806","first-page":"CD006686","article-title":"Beta-2 receptor antagonists for acute traumatic brain injury","volume":"2008","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"issue":"9","key":"bib13-20250806","first-page":"CD001048","article-title":"Hypothermia for traumatic brain injury","volume":"9","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"12","key":"bib14-20250806","first-page":"CD000033","article-title":"Barbiturates for acute traumatic brain injury","volume":"12","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"12","key":"bib15-20250806","first-page":"CD008409","article-title":"Progesterone for acute traumatic brain injury","volume":"12","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"14","key":"bib16-20250806","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1089\/neu.2020.7072","article-title":"Progesterone treatment does not decrease serum levels of biomarkers of glial and neuronal cell injury in moderate and severe traumatic brain injury subjects: a secondary analysis of the progesterone for traumatic brain injury, experimental clinical treatment (ProTECT) III trial","volume":"38","year":"2021","journal-title":"J Neurotrauma"},{"issue":"9734","key":"bib17-20250806","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0140-6736(10)60835-5","article-title":"CRASH-2 trial collaborators. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial","volume":"376","year":"2010","journal-title":"Lancet"},{"key":"bib18-20250806","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1471-227X-13-20","article-title":"Tranexamic acid for patients with traumatic brain injury: a randomized, double-blinded, placebo-controlled trial","volume":"13","year":"2013","journal-title":"BMC Emerg Med"},{"issue":"10210","key":"bib19-20250806","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1016\/S0140-6736(19)32233-0","article-title":"Effects of tranexamic acid on death, disability, vascular occlusive events and other morbidities in patients with acute traumatic brain injury (CRASH-3): a randomised, placebo-controlled trial","volume":"394","year":"2019","journal-title":"Lancet"},{"issue":"10","key":"bib20-20250806","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1001\/jama.2020.8958","article-title":"Effect of out-of-hospital Tranexamic acid vs placebo on 6-month functional neurologic outcomes in patients with moderate or severe traumatic brain injury","volume":"324","year":"2020","journal-title":"JAMA"},{"issue":"8","key":"bib21-20250806","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1089\/neu.1998.15.573","article-title":"Structured interviews for the Glasgow outcome scale and the extended Glasgow outcome scale: guidelines for their use","volume":"15","year":"1998","journal-title":"J Neurotrauma"},{"issue":"5","key":"bib22-20250806","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/HTR.0b013e3181d27fe3","article-title":"Measuring outcome in traumatic brain injury treatment trials: recommendations from the traumatic brain injury clinical trials network","volume":"25","year":"2010","journal-title":"J Head Trauma Rehabil"},{"issue":"11","key":"bib23-20250806","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1016\/j.apmr.2010.06.033","article-title":"Recommendations for the use of common outcome measures in traumatic brain injury research","volume":"91","year":"2010","journal-title":"Arch Phys Med Rehabil"},{"issue":"3","key":"bib24-20250806","first-page":"118","article-title":"Disability rating scale for severe head trauma: coma to community","volume":"63","year":"1982","journal-title":"Arch Phys Med Rehabil"},{"issue":"2","key":"bib25-20250806","first-page":"94","article-title":"Reliability and validity of the disability rating scale and the levels of cognitive functioning scale in monitoring recovery from severe head injury","volume":"68","year":"1987","journal-title":"Arch Phys Med Rehabil"},{"issue":"3","key":"bib26-20250806","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1177\/0962280206074463","article-title":"Multiple imputation of discrete and continuous data by fully conditional specification","volume":"16","year":"2007","journal-title":"Stat Methods Med Res"},{"issue":"8","key":"bib27-20250806","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/0895-4356(94)90191-0","article-title":"Clinically useful measures of effect in binary analyses of randomized trials","volume":"47","year":"1994","journal-title":"J Clin Epidemiol"},{"issue":"11","key":"bib28-20250806","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1093\/aje\/kwm223","article-title":"A modified least-squares regression approach to the estimation of risk difference","volume":"166","year":"2007","journal-title":"Am J Epidemiol"},{"issue":"1","key":"bib29-20250806","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.cjtee.2016.02.005","article-title":"The effect of tranexamic acid in traumatic brain injury: a randomized controlled trial","volume":"20","year":"2017","journal-title":"Chin J Traumatol"},{"issue":"13","key":"bib30-20250806","first-page":"iii","article-title":"CRASH-2 (clinical randomisation of an Antifibrinolytic in significant Haemorrhage) intracranial bleeding study: the effect of tranexamic acid in traumatic brain injury\u2013a nested randomised, placebo-controlled trial","volume":"16","year":"2012","journal-title":"Health Technol Assess"},{"key":"bib31-20250806","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.wneu.2018.11.214","article-title":"Effect of Tranexamic acid in patients with traumatic brain injury: a systematic review and Meta-analysis","volume":"123","year":"2019","journal-title":"World Neurosurg"}],"container-title":["Journal of Trauma and Acute Care Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TA.0000000000004354","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T16:06:53Z","timestamp":1754496413000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TA.0000000000004354"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,30]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/ta.0000000000004354","relation":{},"ISSN":["2163-0763","2163-0755"],"issn-type":[{"value":"2163-0763","type":"electronic"},{"value":"2163-0755","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4,30]]}}}